FDA approves Contrave for weight loss

The United States Food and Drug Administration approved Contrave, a combination of naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.

Contrave weight loss results

How does Contrave Compare to Qsymia and Belviq?

In general, Contrave (Naletrexone/Bupropion) is likely to be less effective than Qsymia, a bit more effective than Belviq as trials of those taking Qsymia lost an average of 9 percent of their body weight, while those taking Belviq lost an average of just 3 percent. Clinical trials show those taking Contrave lost an average of 5 percent of their body weight in the same period.

Compare contrave with Belviq, and Qsymia

So, 9 percent of weight loss for Phentermine/Topirmate (Qsymia), 5 percent for Bupropion/Naltrexone(Contrave) and 3 percent for Lorcaserin(Belviq)!

How can W8MD help?

Frequently asked questions

W8MD weight loss, sleep and medspa centers

Brooklyn NY (718) 946 5500

Manhattan - (718) 946 5500

Philadelphia PA - (215) 676 2334

King of Prussia, PA - (215) 676 2334

Cherry Hill NJ - (215) 676 2334

Cost

Our weight loss program cost $50.00 biweekly plus insurance or $130 self pay  

Categories

Start typing and press Enter to search

Shopping Cart